MG132 treatment rescued the Trim21-induced downregulation of ELOA (Fig. 5I), suggesting that Trim21 promotes the proteasome-dependent degradation of ELOA in CRC cells. This evidence concerns the gene TRIM21 and colorectal carcinoma.